Medication List

Name Safe Dose Pharmacologic Class Therapeutic Use Adverse Eff

Acetaminophen – PO: 5–10 mg q4–6h as Opioid agonist (Narcotic Reduces intensity of Overdose res

Hydrocodone needed. analgesic, Antitussive) incoming pain stimuli respiratory dep

(Norco 325/10) Maximum: 15 mg/dose. from sensory nerve skeletal muscle fl

endings, altering pain cold/clammy

perception, emotional cyanosis ext

response to pain; drowsiness prog

suppresses cough reflex. seizures

(Kizior, 2018, p

Acetaminophen PO: 325–650 Central analgesic (Non- Results in antipyresis. Toxicity: Anorexia

(Tylenol oral tablets) narcotic analgesic, Produces analgesic effect. diaphoresis, f

mg q4–6h or
Antipyretic.) vomiting, right
1 g 3–4 times/day.
quadrant tend
Maximum: 4 g/day

Antidote: Acetyl

(Kizior, 2018

Ceftriaxone IM/IV: 1–2 g q12–24h. Antibiotic Treatment of susceptible Nephrotoxicity m

(Rocephin) infections due to gram- esp. in pts w

negative aerobic preexisting rena

organisms, Pts with

some gram-positive history of penicil

organisms including are at increased

respiratory tract, GU tract, developing a

skin and skin structure,

hypersensitivity
bone and joint, intra-
 abdominal, pelvic (Kizior, 2018, p

inflammatory disease

(PID), biliary tract/urinary

tract infections; bacterial

septicemia, meningitis,

perioperative prophylaxis,

acute bacterial otitis

media.

Famotidine PO: 10–20 mg Antiulcer, gastric acid Short-term treatment of Agranulocyt

secretion inhibitor. active duodenal ulcer. pancytope

q12h. May take 15–60
Prevention, maintenance thrombocytopen
min before eating.
of duodenal ulcer rarely.
Maximum: 2 doses/day.
recurrence. Treatment of (Kizior, 2018, p

active benign gastric ulcer,

pathologic

GI hypersecretory

conditions. Short-term

treatment of

gastroesophageal reflux

disease (GERD).
Fentanyl IM/IV: 25–100 mcg/dose Opioid, narcotic agonist. Pain relief, preop Overdose or too-rapid IV

(INJ) q1–2h as needed. Analgesic. medication; adjunct to administration may

general or produce severe

respiratory depression,
regional anesthesia.
skeletal/thoracic muscle

rigidity.

(Kizior, 2018, p. 1102)

Ketorolac IV: 30 mg once or 30 mg NSAID. Analgesic, Short-term (5 days or less) Peptic ulcer, GI bleeding,

(Toradol) q6h. intraocular relief of mild to moderate gastritis, severe hepatic

pain. reaction (cholestasis,

Maximum: 120 mg/24 anti-inflammatory.
jaundice) occur rarely.
hrs.
Nephrotoxicity may occur

in pts with preexisting

renal impairment.

(Kizior, 2018, p. 1427)

Morphine IV: 2.5–5 mg q3–4h as Narcotic agonist. Opiate Relief of moderate to Overdose results in

(INJ) needed. analgesic. severe, acute, or chronic respiratory depression,

Note: Repeated pain; analgesia during skeletal muscle flaccidity,

labor, pain due to MI,

doses (e.g., 1–2 mg) may cold/clammy skin,
dyspnea from pulmonary
be given more frequently cyanosis, extreme
edema not resulting from
(e.g., every hr) if needed. drowsiness progressing to
chemical respiratory
seizures, stupor, coma.
irritant.
(Kizior, 2018, p. 1703)
Magnesium Sulfate IV: 1–2 g/hr for 3–6 hrs, Antacid, anticonvulsant, Treatment/prevention of Magnesium as antacid,

then 0.5–1 g/hr as needed electrolyte, laxative. hypomagnesemia; laxative has no known

prevention and treatment adverse reactions.

to correct deficiency.
of seizures in severe Systemic use

preeclampsia or
may produce prolonged
eclampsia; pediatric acute
PR interval, widening of
nephritis, treatment
QRS interval. Magnesium

of arrhythmias due to
toxicity may cause loss of
hypomagnesemia.
deep tendon reflexes,

heart block, respiratory

paralysis, cardiac arrest.

(Kizior, 2018, p. 1568)

Ondansetron PO: 16 mg 1 hr before Selective serotonin and 5- Prevention and treatment Hypertension, acute renal

(Zofran) induction of anesthesia. HT3 receptor antagonist. of postop nausea, failure, GI bleeding,

vomiting. respiratory depression,

Antinausea, antiemetic.
coma,
Prevention of radiation-

induced nausea, vomiting. extrapyramidal effects

occur rarely.

(Kizior, 2018, p. 1858)

Sodium Chloride IV: 5mL, 10mL Salt. Electrolyte, isotonic Source of hydration; Too-rapid administration

(0.9% Saline) prevention/treatment of may produce peripheral

volume expander,
sodium, chloride edema, HF, pulmonary
ophthalmic adjunct,
edema.
bronchodilator. deficiencies (hypertonic

for severe deficiencies). Excessive dosage may

Prevention of muscle produce hypokalemia,

 cramps, hypervolemia,

hypernatremia.
heat prostration occurring
(Kizior, 2018, p. 1081)
with excessive

perspiration.